Yes, I understand those changes. But I can't see how they will make the difference between SKI deciding to not acquire 669M shares by 31 Dec and then acquiring them before 20 Feb.
The 'Government backing' is real but confined to assistance with DA at this stage. There is no financial backing.
As far as Bergen is concerned, acquisition by SKI by 31 Dec would certainly have triggered the Bergen termination, thereby removing the 'thorn'.
- Forums
- ASX - By Stock
- Ann: Quarterly Cashflow Report
Yes, I understand those changes. But I can't see how they will...
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $13.98M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.0¢ | $117.7K | 11.54M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 25553334 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 3530000 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 25553334 | 0.009 |
21 | 21036611 | 0.008 |
47 | 36492312 | 0.007 |
21 | 56440113 | 0.006 |
14 | 41900200 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 3530000 | 8 |
0.012 | 3676805 | 17 |
0.013 | 5163031 | 13 |
0.014 | 1712409 | 5 |
0.015 | 2625060 | 9 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
AUZ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online